Is Strategy Inc (MSTR) a risky stock?
As of July 27, 2026, Clavix grades Strategy Inc (MSTR) F for risk, a composite score of 34 out of 100 on an A+ to F scale, which puts MSTR in the "distressed" band. The grade is a risk read for educational purposes, not a buy or sell recommendation.
Grade as of July 27, 2026. Clavix regrades every trading day.
MSTR price, last 3 months
MSTR's daily closes over the past three months. Clavix reads risk from the fundamentals and news behind the price, not the line itself.
The five risk dimensions behind MSTR's grade
Each Clavix grade is a composite of five independent reads. Higher is safer. Here is how MSTR scores on each, as of July 27, 2026.
What's moving MSTR's risk right now
Company-specific signals Clavix flags behind MSTR's current grade, drawn from recent news and filings as of July 27, 2026.
MSTR's reversal from its long-standing Bitcoin accumulation strategy signals potential liquidity stress or a strategic pivot, which could weigh on its stock as the market digests…
The new metrics could improve transparency for retail and common investors, potentially attracting more capital by making MSTR's Bitcoin exposure easier to evaluate on a per-share…
The new metric aims to improve transparency for MSTR common shareholders by isolating the Bitcoin backing attributable to them after accounting for senior debt obligations, potent…
Recent MSTR news
The latest headlines Clavix ingested for Strategy Inc, newest first. These feed the news-sentiment dimension of MSTR's grade.
-
Strategy's STRC preferred stock has become the largest holding in three major U.S. preferred stock ETFs, which collectively hold $756 million of the security, even though it trades roughly 13% below its $100 par value. The article was cut off before additional context from Michael Saylor was provided, limiting further detail.
What a F grade means
On the Clavix A+ to F scale, MSTR's composite of 34 falls in the F band (0–34), read as "distressed." The scale is fixed, so the meaning never moves.
This page is generated from Clavix's own risk model and is for educational purposes only. It is not investment advice or a recommendation to buy or sell MSTR or any security. Grades are risk indicators, not predictions of return. Data may be delayed.